Jaime Manzanera Gómez,Brand Director of Oncology,Eisai EMEAA Marketer's Guide to Strategically Promoting Oncology Innovation14Roswitha Reisinger,SVP General Counsel & Chief Compliance Officer,Kyowa Kirin InternationalHow to Best Navigate Innovation and Ethics in Life Sciences Compliance16Sophie Toya,MD, Associate Director,Clinical Development,DompéCasting Our "NETs" for ARDS19Charlotte Stadler,Co-Director Spatial Biology Platform,SciLifeLabStaff scientists are the technology experts within academic life science research20Rafael Sande,Head Operations Characterization,Large Molecules and ATMP Services, Solvias AGEarly Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product Developments22Rüdiger Schulze,Vice President and General Manager,DACH,UltragenyxESTABLISHING A BIOTECH COMPANY IN EUROPE:A MISSION IMPOSSIBLE?26Nicholas Smalley,Vice President of Regulatory Affairs,Kindeva Drug DeliveryFrom Complex to Compliance: 3 Keys for Unlocking the Regulatory Pathway24Andreas Søderman,Head of Medical Affairs,OrifarmThe Untapped Potential of Medical Affairs in Generics,Value added medicines and Hybrid pharmaceuticals18CXO INSIGHTSCXO INSIGHTSCANCER IMMUNOTHERAPYTOP 10SOLUTIONS PROVIDERS IN EUROPE - 2024PG - 28
< Page 4 | Page 6 >